A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients
about
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsAntiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsNew strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsAcyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipientsGuidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.Prevention of infections in solid organ transplant recipients.Prevention and treatment of cytomegalovirus infection in organ transplant recipients.Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.Infections in solid-organ transplant recipientsCytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients.Universal prophylaxis or preemptive strategy for cytomegalovirus disease after liver transplantation: a systematic review and meta-analysis.Management of cytomegalovirus infection in solid-organ transplant recipients.Cytomegalovirus infection after liver transplantation: current concepts and challenges.Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
P2860
Q24200697-17DBD920-0D4C-4E4D-87B2-CED169306141Q24243124-276C645E-6413-4C5E-BBF1-158C324F9FA5Q33812425-51BFA2C9-3B11-4E7D-AF63-853C58C18EF8Q34178600-E38F1080-E514-4AC9-ADCE-7C61B77812C4Q34257412-DF1958C1-D926-45F0-AAA1-87BE3DB42AC3Q34294796-B214EB86-37D0-4A31-AF15-F8A42E7A09DAQ34294851-970CB0AF-2C36-4E93-96F2-E54B9486D656Q34481742-C4339273-1A7E-41C5-B5D5-6A6A223126C4Q35376486-9A491B52-E8B8-4221-840A-D23357DCFCABQ37034498-DB13DBE6-99A7-41DE-B6B3-784343A39016Q37229975-7FBE8651-4475-4923-94D9-57B2D0E73655Q38293175-4CD63FB1-4212-4A5A-9243-F63006626963Q41351279-4DC7938A-B886-4010-B3C0-41B6BF9AE302Q42549311-BD675739-B33E-480F-9F53-783F16861C3EQ43894083-DF1A8D27-A457-4912-BF99-D81C5DB1E3DC
P2860
A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
A prospective randomized trial ...... lt liver transplant recipients
@ast
A prospective randomized trial ...... lt liver transplant recipients
@en
A prospective randomized trial ...... lt liver transplant recipients
@nl
type
label
A prospective randomized trial ...... lt liver transplant recipients
@ast
A prospective randomized trial ...... lt liver transplant recipients
@en
A prospective randomized trial ...... lt liver transplant recipients
@nl
prefLabel
A prospective randomized trial ...... lt liver transplant recipients
@ast
A prospective randomized trial ...... lt liver transplant recipients
@en
A prospective randomized trial ...... lt liver transplant recipients
@nl
P2093
P2860
P1433
P1476
A prospective randomized trial ...... lt liver transplant recipients
@en
P2093
J Torre-Cisneros
R Ptachcinski
P2860
P304
P356
10.1097/00007890-199410150-00005
P50
P577
1994-10-01T00:00:00Z